Hydrochlorothiazide Tablet
Product Images NDC 0228-2820

3 FDA label images from Actavis Pharma, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Hydrochlorothiazide (NDC 0228-2820). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Image 1

Image 1
Chemical structure diagram of Hydrochlorothiazide, showing the molecular arrangement with chlorine, sulfur, oxygen, nitrogen, and hydrogen atoms included in the structure.*
FDA Label Image

Image 2

Image 2
Hydrochlorothiazide 12.5 mg oral tablets blister pack by Actavis Pharma, Inc. The blister contains 10 round, white tablets individually sealed in a silver foil backing with clear plastic pockets. The pack shows basic labeling with the product name and strength visible on the foil backing.*
FDA Label Image

Image 3

Image 3
Label of Hydrochlorothiazide Tablets, USP 12.5 mg oral tablets by Actavis Pharma, Inc. The label shows a single round tan tablet imprinted with '20', package contains 100 tablets, Rx only. It includes NDC 0228-2820-11, manufacturer and distributor information, storage instructions, and dosage additive details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.